Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions

Por Mahamid, Mahmud, Mader, Reuven, Safadi, Rifaat
Publicado em 2011

Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs

Por Bakacs, Tibor, Safadi, Rifaat, Kovesdi, Imre
Publicado no Hepatol Med Policy (2018)

Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports

Por Mahamid, Mahmud, Paz, Kalman, Reuven, Mader, Safadi, Rifaat
Publicado em 2011

Malignant deep brain stimulator withdrawal syndrome

Por Azar, Jehad, Elinav, Hila, Safadi, Rifaat, Soliman, Mona
Publicado no BMJ Case Rep (2019)

25(OH) D3 alleviate liver NK cytotoxicity in acute but not in chronic fibrosis model of BALB/c mice due to modulations in vitamin D receptor

Por Salhab, Ahmad, Amer, Johnny, Yinying, Lu, Safadi, Rifaat
Publicado no BMC Gastroenterol (2020)

Case report: successful retreatment of hepatitis C genotype 1b infection with sofosbuvir + simeprevir in a patient with cirrhosis who had prior virologic relapse after treatment wi...

Por Safadi, Rifaat, Noviello, Stephanie, Boparai, Navdeep, McPhee, Fiona
Publicado no Clin Case Rep (2016)

Low Serum Lysosomal Acid Lipase Activity Correlates with Advanced Liver Disease

Por Shteyer, Eyal, Villenchik, Rivka, Mahamid, Mahmud, Nator, Nidaa, Safadi, Rifaat
Publicado no Int J Mol Sci (2016)

The Immune Interplay between Thyroid Papillary Carcinoma and Hepatic Fibrosis

Por Muhanna, Nidal, Amer, Johnny, Salhab, Ahmad, Sichel, Jean-Yves, Safadi, Rifaat
Publicado no PLoS One (2015)

The A3 adenosine receptor agonist, namodenoson, ameliorates non-alcoholic steatohepatitis in mice

Por Fishman, Pnina, Cohen, Shira, Itzhak, Inbal, Amer, Johnny, Salhab, Ahmad, Barer, Faina, Safadi, Rifaat
Publicado no Int J Mol Med (2019)

A Transgenic Model for Conditional Induction and Rescue of Portal Hypertension Reveals a Role of VEGF-Mediated Regulation of Sinusoidal Fenestrations

Por May, Dalit, Djonov, Valentin, Zamir, Gideon, Bala, Miklosh, Safadi, Rifaat, Sklair-Levy, Miriam, Keshet, Eli
Publicado em 2011

Activation of Hepatic Stellate Cells After Phagocytosis of Lymphocytes: A Novel Pathway of Fibrogenesis

Por Muhanna, Nidal, Doron, Sarit, Wald, Ori, Horani, Amjad, Eid, Ahmed, Pappo, Orit, Friedman, Scott L., Safadi, Rifaat
Publicado em 2008

Insulin signaling as a potential natural killer cell checkpoint in fatty liver disease

Por Amer, Johnny, Salhab, Ahmad, Noureddin, Mazen, Doron, Sarit, Abu‐Tair, Lina, Ghantous, Rami, Mahamid, Mahmud, Safadi, Rifaat
Publicado no Hepatol Commun (2018)

Natural Killer Cell-Dependent Anti-Fibrotic Pathway in Liver Injury via Toll-Like Receptor-9

Por Abu-Tair, Lina, Axelrod, Jonathan H., Doron, Sarit, Ovadya, Yossi, Krizhanovsky, Valery, Galun, Eithan, Amer, Johnny, Safadi, Rifaat
Publicado em 2013

Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease

Por Daher, Saleh, Lev Cohen, Namma, Massarwa, Muhammad, Mahamid, Mahmud, Nasser, Mira, Hazou, Wadi, Oren, Rani, Safadi, Rifaat, Khoury, Tawfik
Publicado no PLoS One (2018)

Endoscopic Ultrasound‐Guided Angiotherapy for Gastric Varices: A Single Center Experience

Por Khoury, Tawfik, Massarwa, Muhammad, Daher, Saleh, Benson, Ariel A., Hazou, Wadi, Israeli, Eran, Jacob, Harold, Epstein, Julia, Safadi, Rifaat
Publicado no Hepatol Commun (2018)

Parameters Suggesting Spontaneous Passage of Stones from Common Bile Duct: A Retrospective Study

Por Khoury, Tawfik, Adileh, Mohamed, Imam, Ashraf, Azraq, Yosef, Bilitzky-Kopit, Avital, Massarwa, Muhamad, Benson, Ari, Bahouth, Zaher, Abu-Gazaleh, Samir, Sbeit, Wisam, Safadi, Rifaat, Khalaileh, Abed
Publicado no Can J Gastroenterol Hepatol (2019)

Interleukin-6 protects hepatocytes from CCl(4)-mediated necrosis and apoptosis in mice by reducing MMP-2 expression

Por Bansal, Meena B., Kovalovich, Kellen, Gupta, Ritu, Li, Wei, Agarwal, Akansha, Radbill, Brian, Alvarez, Carlos E., Safadi, Rifaat, Fiel, M. Isabel, Friedman, Scott L., Taub, Rebecca A.
Publicado em 2005

Associations between B-cell non-Hodgkin lymphoma and exposure, persistence and immune response to hepatitis B

Por Kleinstern, Geffen, Seir, Rania Abu, Perlman, Riki, Abdeen, Ziad, Khatib, Areej, Elyan, Husein, Dann, Eldad J., Kedmi, Meirav, Ellis, Martin, Nagler, Arnon, Amir, Gail, Ben Yehuda, Dina, Safadi, Rifaat, Paltiel, Ora
Publicado no Haematologica (2016)

Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo

Por Du, Guifang, Wang, Jing, Zhang, Ting, Ding, Qiang, Jia, Xiaodong, Zhao, Xueke, Dong, Jinke, Yang, Xinrui, Lu, Shanshan, Zhang, Cuihong, Liu, Ze, Zeng, Zhen, Safadi, Rifaat, Qi, Ruizhao, Zhao, Xin, Hong, Zhixian, Lu, Yinying
Publicado no Cell Death Dis (2020)

Characterization of hepatitis B and delta coinfection in Israel

Por Shirazi, Rachel, Ram, Daniela, Rakovsky, Aviya, Bucris, Efrat, Gozlan, Yael, Lustig, Yaniv, Shaked-Mishan, Pninit, Picard, Orit, Shemer-Avni, Yonat, Ben-Zvi, Haim, Halutz, Ora, Lurie, Yoav, Veizman, Ella, Carlebach, Matthias, Braun, Marius, Naftaly, Michal Cohen-, Shlomai, Amir, Safadi, Rifaat, Mendelson, Ella, Sklan, Ella H., Ben-Ari, Ziv, Mor, Orna
Publicado no BMC Infect Dis (2018)